Bayban’s Novartis NVS Stock Holding History

Bayban's NVS Position: Q2 2026 in Review

Bayban held its Novartis (NVS) position steady in Q2 2026 at 229 shares worth $35.9K. The position accounts for 0.03% of the portfolio, ranked #279.

Bayban first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. 1,546 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

• Bayban held 229 shares of Novartis worth $35.9K as of Q2 2026.
• Bayban left its Novartis share count unchanged in Q2 2026.
• Novartis made up 0.03% of Bayban's portfolio in Q2 2026, its #279 holding.
• Bayban first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
• 1,546 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.